Condition
Nocturnal Enuresis in Children
Total Trials
5
Recruiting
3
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 3 (1)
Trial Status
Recruiting3
Not Yet Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07508111Not Yet Recruiting
Causes and Types of Nocturnal Enuresis in Children
NCT06771128Not ApplicableCompletedPrimary
Ginkgo Biloba vs Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis
NCT07199894Phase 3RecruitingPrimary
Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE
NCT06883851Not ApplicableRecruiting
Effectiveness of Pelvic Floor Muscle Rehabilitation Combined With Desmopressin in Children With Primary Monosymptomatic Nocturnal Enuresis
NCT06497647Not ApplicableRecruitingPrimary
New Treatment for Nocturnal Enuresis in Children
Showing all 5 trials